Request: Seeking a biomedical engineer or science student, post-doc, or recent graduate for 6-12 month paid internship performing Installation Qualification (IQ)/Operational Qualification (OQ)/Performance Qualification (PQ) services for leading pharma, biotech, and cellular therapy labs in the country.

When: Starts immediately. Services can be performed over the weekend. For example, we’d fly you out on Friday night, put you in a hotel next to the hospital or the manufacturing plant, and then fly you back on Sunday night. You need to live next to a major airport.

Where: Barkey will fly you out to the location. These are typically major cancer centers in large cities, like MD Anderson in Houston or Dana-Faber in Boston.

Time Commitment: 1-2 weekends, or blocks of 2 consecutive days, onsite 1-2 times a month.

Why do this? If you are an engineer or scientist, you’ll be the only one gaining insider knowledge and on-the-ground networking in the exploding cell and gene therapy field by feet-on-the-ground visiting the new built manufacturing sites and newly created cellular therapy labs.

What’s Involved: A Barkey engineer will guide you through the steps of remote IQOQPQ installation services. These are scientific validation testing and recording.

Future Potential: Because of COVID19 and the travel ban, Barkey is unable to fly our engineers in from Germany, like we normally do. We are building a fully US-based team. If this is a good fit, we are interested in recruiting 2-5 hires for full-time positions.

Who will you report to? You will report to Jennifer Joe, MD (https://www.linkedin.com/in/jenniferjoemd/), Barkey Science Liaison, located in Boston, Massachusetts. From Mississippi, Dr. Joe trained in internal medicine at Georgetown, and then in nephrology at MGH/BWH. She is a healthcare executive and entrepreneur who has founded and sold 2 companies. She currently practices emergency medicine at three of the Boston VA hospitals.

About Barkey: Founder in 1980, Barkey is a small family-owned manufacturing company located in northern Germany. Since 1984, Barkey has been manufacturing the plasmatherm, which is widely used in hospital blood banks for thawing plasma, and more recently has been the gold standard for thawing sensitive T-cells since being written into the manufacturing patent for Novartis’s Kymriah, the first FDA approved CAR-T therapy. The plasmatherm is widely used in both cell and gene therapy manufacturing and by the patient bedside immediately before infusion. Link: https://barkey.de/en/

Who do I contact to learn more? Email or call Jennifer Joe, MD, at jen@vanguard.health or 601.667.9470. Please send your CV with the email.